z-logo
open-access-imgOpen Access
Acquired Factor V Inhibitor Developing After Percutaneous Ethanol Injection Therapy for Hepatocellular Carcinoma
Author(s) -
Maeda
Publication year - 2011
Publication title -
journal of medical cases
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1923-4163
pISSN - 1923-4155
DOI - 10.4021/jmc21w
Subject(s) - medicine , percutaneous ethanol injection , hepatocellular carcinoma , partial thromboplastin time , cirrhosis , prothrombin time , gastroenterology , liver function , factor ix , fresh frozen plasma , chronic hepatitis , coagulation , surgery , immunology , platelet , virus , ablation , radiofrequency ablation

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom